Rare diseases
Investigational molecules
Locations
Back to the Netherlands8 clinical trials in Born, The Netherlands. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in the NetherlandsKlinischOnderzoek.nl(opens in a new tab)The NetherlandsStudy on the Effectiveness and Safety of Tanimilast for Patients with Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis
The NetherlandsStudy on the Effectiveness and Safety of CHF6001 DPI with Roflumilast for Patients with Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis
The NetherlandsWeight loss in adults with obesity (with or without type 2 diabetes) using cagrilintide and semaglutide: a study of two dose levels versus semaglutide alone
The NetherlandsA study to evaluate the efficacy and safety of zenagamtide in people with obesity
The NetherlandsA study testing MK-1167 added to current treatment in patients with mild to moderate Alzheimer's disease dementia
The NetherlandsStudy on the Effectiveness of Survodutide for Weight Loss in Patients with Type 2 Diabetes and Obesity
The NetherlandsStudy on the Effectiveness of Survodutide for Weight Loss in Adults with Obesity Without Diabetes
The NetherlandsThe busiest research cities in the country
What the registry says about research in the country
Innovative research exploring heart failure prevention through combination therapy approaches, specifically investigating new treatments alongside established medications to reduce cardiovascular events.
Studies focus on evaluating therapeutic combinations for optimal cardiovascular outcomes.
Comprehensive studies addressing obesity management and Type 2 diabetes, investigating new therapeutic options for weight management both with and without diabetes complications.
Research combines medication therapy with lifestyle modifications for improved patient outcomes.
Advanced research into Alzheimer's disease treatments, examining new therapeutic approaches as adjunctive therapy to existing treatments for mild to moderate dementia.
Focus on developing improved therapeutic options for neurodegenerative conditions.
Cutting-edge research in COPD treatment, investigating enhanced therapeutic approaches through triple therapy combinations and new drug applications.
Studies aim to improve long-term outcomes for patients with chronic respiratory conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
